Long-term in vitro expansion of human adipose-derived stem cells showed low risk of tumourigenicity

Journal of Tissue Engineering and Regenerative Medicine
Wan Safwani Wan Kamarul ZamanKien Hui Chua

Abstract

In the field of cell-based therapy and regenerative medicine, clinical application is the ultimate goal. However, one major concern is: does in vitro manipulation during culture expansion increases tumourigenicity risk on the prepared cells? Therefore, the aim of this study was to investigate the effect of long-term in vitro expansion on human adipose-derived stem cells (ASCs). The ASCs were harvested from lipo-aspirate samples and cultured until passage 20 (P20), using standard culture procedures. ASCs at P5, P10, P15 and P20 were analysed for morphological changes, DNA damage (Comet assay), tumour suppressor gene expression level (quantitative PCR), p53 mutation, telomerase activity, telomere length determination and in vivo tumourigenicity test. Our data showed that ASCs lost their fibroblastic feature in long-term culture. The population doubling time of ASCs increased with long-term culture especially at P15 and P20. There was an increase in DNA damage at later passages (P15 and P20). No significant changes were observed in both p53 and p21 genes expression throughout the long-term culture. There was also no p53 mutation detected and no significant changes were recorded in the relative telomerase activity (RTA) and mean te...Continue Reading

References

Jul 28, 1995·Biochimica Et Biophysica Acta·P J Vojta, J C Barrett
Feb 1, 1993·PCR Methods and Applications·W C KusserB W Glickman
Aug 12, 1998·International Journal of Cancer. Journal International Du Cancer·G RoosG Landberg
May 19, 2001·European Journal of Biochemistry·K ItahanaJ Campisi
May 30, 2001·Trends in Molecular Medicine·A I Caplan, S P Bruder
Aug 4, 2001·The American Journal of Pathology·K S Elenitoba-Johnson
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·A KrtolicaJ Campisi
Nov 15, 2002·The New England Journal of Medicine·William C Hahn, Robert A Weinberg
Nov 11, 2003·Fertility and Sterility·Liza DawsonRuth R Faden
Jan 1, 2004·The Journal of Clinical Investigation·Pier Giuseppe Pelicci
Apr 27, 2004·Oncogene·Nedime SerakinciMoustapha Kassem
Aug 25, 2004·Cancer Cell·Annapoorni RangarajanRobert A Weinberg
Apr 19, 2005·Cancer Research·Daniel RubioAntonio Bernad
Aug 6, 2005·Stem Cells·Toshio MikiStephen C Strom
Nov 29, 2005·Ageing Research Reviews·Sebastian SetheAlexandra Stolzing
May 3, 2006·Cancer Research·Linheng Li, William B Neaves
May 31, 2006·Journal of Atherosclerosis and Thrombosis·Hironori NakagamiYasufumi Kaneda
Jun 29, 2006·Annals of the New York Academy of Sciences·Christine FehrerGünter Lepperdinger
Sep 16, 2006·Biomaterials·Cheryl T Gomillion, Karen J L Burg
Jan 11, 2007·Genes & Development·Frédérick A MalletteGerardo Ferbeyre
Jul 11, 2007·Journal of Cellular Physiology·Arnold I Caplan
Apr 19, 2008·Journal of Cellular and Molecular Medicine·Leonardo A Meza-ZepedaPhilippe Collas
Jun 4, 2008·Cancer Research·Reza IzadpanahBruce A Bunnell
Aug 16, 2011·Biotechnology and Applied Biochemistry·Wan Kamarul Zaman Wan SafwaniKien Hui Chua

❮ Previous
Next ❯

Citations

Oct 27, 2015·Aesthetic Surgery Journal·Michela MassaErica Repaci
Jul 18, 2014·Revista brasileira de hematologia e hemoterapia·Déborah Afonso Cornélio, Silvia Regina Batistuzzo de Medeiros
May 13, 2014·Cell Transplantation·Tzu-Min ChanShinn-Zong Lin
Mar 7, 2018·Regenerative Medicine·Kar Wey YongWan Kamarul Zaman Wan Safwani
May 10, 2018·Muscle & Nerve·K Ming ChanChristine A Webber
Aug 8, 2014·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Jiovanni A Di BattistaWissam H Faour
Apr 20, 2016·The Journal of Craniofacial Surgery·Kemalettin YildizEthem Güneren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.